[Triglycerides - assessment as risk factor and therapeutic goals]

Area of Science:

• Cardiovascular Medicine
• Endocrinology
• Lipidology

Background:

• Elevated triglycerides are an independent cardiovascular risk factor.
• Associated lipid abnormalities include small, dense LDL and reduced HDL cholesterol.
• Hypertriglyceridemia significantly increases cardiovascular morbidity and mortality, particularly in diabetes mellitus.

Purpose of the Study:

• To provide an overview of the current scientific understanding of hypertriglyceridemia.
• To discuss the pathogenesis and clinical significance of elevated triglycerides.
• To highlight the link between hypertriglyceridemia and cardiovascular disease.

Main Methods:

• Literature review of current scientific status.
• Synthesis of information on pathogenesis.
• Analysis of clinical significance and implications.

Main Results:

• Hypertriglyceridemia leads to atherogenic lipid profiles (small, dense LDL, remnants).
• It is a primary driver of cardiovascular complications in diabetes mellitus.
• Very high levels pose a risk for acute pancreatitis.

Conclusions:

• Hypertriglyceridemia is a critical, independent cardiovascular risk factor.
• Management is essential, especially in diabetic patients, to reduce morbidity and mortality.
• Understanding its pathogenesis is key to effective clinical intervention.